Traders are focused on the API report today as the market awaits new catalysts to send prices moving again.
Among the securities that traders are also watching are several major tech companies and one life sciences company, Twitter Inc (NYSE:TWTR), salesforce.com, inc. (NYSE:CRM), Illumina, Inc. (NASDAQ:ILMN), Yahoo! Inc. (NASDAQ:YHOO), and Verizon Communications Inc. (NYSE:VZ). Let’s find out why investors are talking about the five stocks and use data from 13F filings to determine the hedge fund sentiment toward each stock.
We believe that imitating hedge funds and other large institutional investors can be helpful in identifying stocks capable of outperforming the broader market. Through extensive research that covered portfolios of several hundred large investors between 1999 and 2012, we determined that following the small-cap stocks that large money managers are collectively bullish on, can generate monthly returns nearly 1.0 percentage points above the market (see the details here).
Although many traders gave up on the possibility of a Twitter Inc (NYSE:TWTR) buyout as shares of the company fell 11.5% on Monday to below $18 a piece, there may still be some chance of a bid. According to Reuters, salesforce.com, inc. (NYSE:CRM) is ‘still deliberating whether it should make an offer’ for the social media company. According to Reuters’ sources, Salesforce management is debating as to whether it should make a ‘lowball’ offer in light of Twitter’s lower price and the lack of other bidders. Given the lack of apparent synergies between the two companies, many of Salesforce’s major shareholders are against the acquisition. However, Salesforce’s CEO Marc Benioff has never really followed conventional wisdom. If there is a bid, the bid might be too low for Twitter to accept or it might just be enough to satisfy both companies’ shareholders. Of the 749 funds that we track, 30 were long Twitter Inc (NYSE:TWTR) and 60 funds held shares of salesforce.com, inc. (NYSE:CRM) at the end of June.
Illumina, Inc. (NASDAQ:ILMN) shares have fallen by over 24% after the company reported preliminary revenue for its third quarter of fiscal 2016. For the three months, Illumina estimates its sales at $607 million, or considerably lower than management’s previous guidance of between $625 million and $630 million. According to the company, the shortfall was driven by a larger than anticipated year-over-year decline in high throughput sequencing instruments. Due to lower demand, the company expects its fourth quarter sales to be flat to slightly up sequentially. Philippe Laffont’s Coatue Management raised its stake in Illumina, Inc. (NASDAQ:ILMN) by 19% to 572,623 shares during the second quarter.
On the next page, we will examine Yahoo, and Verizon Communications.